| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,711 | 1,262 | 1,279 | 1,352 | | Cost of Revenue | 702 | 522 | 521 | 546 | | | Gross Profit | 1,009 | 740 | 758 | 806 | | | Operating Expenses | | Research Development | 144 | 160 | 168 | 163 | | Selling General and Administrative | 608 | 599 | 643 | 603 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 257 | (19) | (53) | 40 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9 | 7 | 5 | 9 | | Earnings Before Interest And Taxes | 266 | (12) | (48) | 49 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 266 | (12) | (48) | 49 | | Income Tax Expense | 106 | (5) | (19) | 32 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 160 | (7) | (29) | 17 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 160 | (7) | (29) | 17 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $160 | ($7) | ($29) | $17 |
|
0.45% Nasdaq 
Income Statement
